Edges in Network
| Network | GSE25066_egf1520 - GSE25066 - SiGN-BN HC+Bootstrap |
| Network Description | Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | HLA-G |
| Upstream (Parents) |
|---|
| (<<) ACTB → HLA-G |
| (<<) ARHGAP25 → HLA-G |
| (<<) CASP1 → HLA-G |
| (<<) CD4 → HLA-G |
| (<<) CORO1A → HLA-G |
| (<<) ENO1 → HLA-G |
| (<<) HLA-A → HLA-G |
| (<<) HLA-F → HLA-G |
| (<<) HSP90AB1 → HLA-G |
| (<<) IRF1 → HLA-G |
| (<<) LPXN → HLA-G |
| (<<) LTB → HLA-G |
| (<<) MCL1 → HLA-G |
| (<<) MPP1 → HLA-G |
| (<<) MSN → HLA-G |
| (<<) PIK3CD → HLA-G |
| (<<) RAC2 → HLA-G |
| (<<) STK17B → HLA-G |
| (<<) TNFAIP3 → HLA-G |
| Downstream (Children) |
|---|
| HLA-G → ADAM19 (>>) |
| HLA-G → ADAM8 (>>) |
| HLA-G → BRCA1 (>>) |
| HLA-G → BZW2 (>>) |
| HLA-G → CCND3 (>>) |
| HLA-G → DVL1 (>>) |
| HLA-G → FAS (>>) |
| HLA-G → FZD5 (>>) |
| HLA-G → GLRX (>>) |
| HLA-G → GNA13 (>>) |
| HLA-G → GRB10 (>>) |
| HLA-G → HBEGF (>>) |
| HLA-G → IFITM3 (>>) |
| HLA-G → IL18 (>>) |
| HLA-G → LIMK1 (>>) |
| HLA-G → LSM1 (>>) |
| HLA-G → MMP9 (>>) |
| HLA-G → NFKB1 (>>) |
| HLA-G → NFKBIE (>>) |
| HLA-G → OGFR (>>) |
| HLA-G → PLCH2 (>>) |
| HLA-G → POP1 (>>) |
| HLA-G → SIGLEC15 (>>) |
| HLA-G → SMAD1 (>>) |
| HLA-G → STAT1 (>>) |
| HLA-G → SULT2B1 (>>) |
| HLA-G → TGM2 (>>) |
| HLA-G → TPP1 (>>) |
| HLA-G → UBE2D2 (>>) |
| HLA-G → UBE2L6 (>>) |
| HLA-G → WNT7B (>>) |
| HLA-G → ZBED2 (>>) |
